Hong Kong Marine and Shipping Stock News

SEHK:17
SEHK:17Real Estate

Assessing New World Development (SEHK:17) Valuation After Recent Share Price Weakness

New World Development (SEHK:17) has drawn attention after a period of mixed share performance, with the stock down 3% over the past week and about 21% over the past 3 months. See our latest analysis for New World Development. Zooming out, the share price has fallen 21.3% over the past 90 days despite an 11.6% year to date share price return and an 81.3% total shareholder return over the past year. This suggests earlier momentum has faded recently as investors reassess risk and recovery...
SEHK:2618
SEHK:2618Logistics

Assessing JD Logistics (SEHK:2618) Valuation After Recent Share Price Pullback

Recent performance context for JD Logistics JD Logistics (SEHK:2618) has drawn attention after a recent pullback, with the stock down 12% over the past month, up about 20% in the past 3 months, and up 9% over the past year. See our latest analysis for JD Logistics. At a share price of HK$13.32, JD Logistics has seen short term momentum cool, with the 1 month share price return down 11.73%, even though the 1 year total shareholder return is 9.36%. This suggests longer term holders have fared...
SEHK:8418
SEHK:8418Specialty Retail

Discover Asian Penny Stocks With Market Caps Under US$700M

As global markets navigate a landscape marked by inflation concerns and geopolitical tensions, the Asian market remains a focal point for investors seeking growth opportunities. Penny stocks, often representing smaller or newer companies, continue to intrigue those looking for potential value beyond mainstream investments. Despite their vintage name, these stocks can offer surprising resilience and stability when backed by strong financials. This article explores three such penny stocks in...
SEHK:1810
SEHK:1810Tech

Xiaomi (SEHK:1810) One Off Gain Driven Margin Jump Tests Bullish Profitability Narrative

Xiaomi (SEHK:1810) has just wrapped up FY 2025 with fourth quarter revenue of CN¥116.9b and basic EPS of CN¥0.25, capping a year in which trailing twelve month revenue reached CN¥457.3b and EPS stood at CN¥1.62 alongside year on year earnings growth of 76%. Over recent periods the company has seen quarterly revenue move from CN¥92.5b in Q3 2024 to CN¥109.0b in Q4 2024 and then into the CN¥111.3b to CN¥116.9b range through FY 2025. Over the same time, trailing net profit margin has shifted...
SEHK:3692
SEHK:3692Pharmaceuticals

Hansoh Pharmaceutical Group’s Valuation After HS-10541 Clinical Trial Approval For KRAS G12C Tumors

Hansoh Pharmaceutical Group (SEHK:3692) has drawn fresh investor attention after announcing that its self developed Class 1 drug candidate HS-10541 received clinical trial approval in China for KRAS G12C mutated advanced solid tumors. See our latest analysis for Hansoh Pharmaceutical Group. The HS-10541 trial approval comes as Hansoh Pharmaceutical Group's share price has softened recently, with a 30 day share price return down 13.62%, even while the 1 year total shareholder return stands at...
SEHK:9660
SEHK:9660Software

Asian Growth Companies With High Insider Ownership In May 2026

As the Asian markets navigate a complex landscape of geopolitical tensions and economic uncertainties, investors are increasingly focused on companies with strong growth potential and significant insider ownership. In this environment, stocks that combine robust internal backing with promising expansion prospects can offer a compelling investment narrative.
SEHK:862
SEHK:862IT

Xtep International Holdings And 2 Other Asian Penny Stocks Worth Watching

As global markets navigate a complex landscape marked by inflation concerns and geopolitical tensions, the Asian market remains a focal point for investors seeking opportunities in emerging sectors. Penny stocks, though an older term, continue to represent smaller or less-established companies that can offer significant value and growth potential. By focusing on those with robust financials and clear growth trajectories, investors might uncover promising opportunities among these lesser-known...
SEHK:2600
SEHK:2600Metals and Mining

A Look At Aluminum Corporation of China (SEHK:2600) Valuation After EV Demand Fuels Talk Of A Technical Rebound

Electric vehicle demand and technical rebound thesis Recent analyst commentary on Aluminum Corporation of China (SEHK:2600) discusses a potential technical rebound, connecting current interest in the stock to aluminum demand associated with the expanding electric vehicle industry. See our latest analysis for Aluminum Corporation of China. At the latest share price of HK$11.88, the stock has seen a sharp 1-day share price return of 9.29% and 7-day share price return of 14.56%, even though the...
SEHK:2696
SEHK:2696Biotechs

Shanghai Henlius Biotech (SEHK:2696) Valuation Check After Positive EMA CHMP Opinion For Serplulimab

Shanghai Henlius Biotech (SEHK:2696) is back on investors’ radar after winning a positive opinion from the EMA’s CHMP for serplulimab plus chemotherapy in first-line advanced squamous non-small cell lung cancer in Europe. See our latest analysis for Shanghai Henlius Biotech. Despite the positive CHMP opinion and a series of product updates, Shanghai Henlius Biotech’s short term share price return has come under pressure, with the 1 month share price return down 17.22%. However, the 1 year...
SEHK:9885
SEHK:9885Healthcare

Nickel Asia And 2 Other Penny Stocks Making Waves In Global

Amidst a backdrop of rising inflation worries and fluctuating consumer sentiment, global markets have shown resilience, with major U.S. stock indexes reaching new highs and small-cap stocks outperforming their larger peers. In such a dynamic market landscape, investors often look beyond the well-trodden paths to discover potential in lesser-known areas like penny stocks. While the term "penny stocks" might seem outdated, these smaller or newer companies can offer unique growth opportunities...
SEHK:1093
SEHK:1093Pharmaceuticals

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After New Autoimmune And Nephrology Drug Approvals

CSPC Pharmaceutical Group (SEHK:1093) has recently secured Chinese approvals for Enyike, a ustekinumab biosimilar, and 4mg budesonide enteric-coated capsules, broadening its autoimmune and nephrology treatment offerings for patients. See our latest analysis for CSPC Pharmaceutical Group. At a latest share price of HK$7.69, the stock has seen a 1-day share price return of 4.77% and a 7-day share price return of 1.45%, but a 90-day share price return that is down 23.56%. The 1-year total...
SEHK:2142
SEHK:2142Biotechs

HBM Holdings (SEHK:2142) Valuation Check After Positive LET003 Obesity Antibody Preclinical Data

HBM Holdings (SEHK:2142) is in focus after Harbour BioMed reported preclinical data for LET003, an ACVR2A/2B-targeting antibody developed using its AI-based Hu-mAtrIx platform, showing superior pharmacokinetics compared with several competitors. See our latest analysis for HBM Holdings. At a share price of HK$12.15, HBM Holdings has seen the 30 day share price return fall 13.21%, even as the 1 year total shareholder return is 37.91% and the 3 year total shareholder return is very large. This...
SEHK:836
SEHK:836Renewable Energy

A Look At China Resources Power Holdings (SEHK:836) Valuation After Strong Photovoltaic Generation Growth In 2026

Why the latest operating data matters for investors China Resources Power Holdings (SEHK:836) has reported new operating figures for April and the first four months of 2026, with higher total net generation supported by strong photovoltaic output, which offset weaker wind generation. See our latest analysis for China Resources Power Holdings. At a share price of HK$20.18, the stock has built clear positive momentum, with a 90-day share price return of 10.27% and a 5-year total shareholder...
SEHK:797
SEHK:797Entertainment

Global Penny Stocks To Watch In May 2026

Amid a backdrop of rising inflation concerns and geopolitical tensions, major U.S. stock indexes have reached new heights, driven by enthusiasm around artificial intelligence stocks and positive earnings reports. As the market landscape continues to evolve, investors might find opportunities in areas often overlooked by mainstream attention. Penny stocks, though sometimes seen as relics of past speculative trends, remain relevant for those seeking growth potential in smaller or newer...